InDex Pharmaceuticals Holding AB (publ) announced that Chief Operating Officer Pernilla Sandwall has decided to leave the company to become CEO of WntResearch, starting at the end of April 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.85 SEK | +2.60% | +15.05% | +28.80% |
05-03 | WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-29 | WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+28.80% | 9.74M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- WNT Stock
- News WntResearch AB
- WntResearch Announces Appointment of Pernilla Sandwall as CEO